MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹27,755 Cr | ₹27,652 Cr | ₹11,883 Cr | ₹9,686 Cr | ₹9,108 Cr |
What is the latest Total Liabilities ratio of MANKIND PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹27,755 Cr |
| Mar2025 | ₹27,652 Cr |
| Mar2024 | ₹11,883 Cr |
| Mar2023 | ₹9,686 Cr |
| Mar2022 | ₹9,108 Cr |
How is Total Liabilities of MANKIND PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹27,755 Cr | 0.37 | |
| Mar2025 | ₹27,652 Cr | 132.70 | |
| Mar2024 | ₹11,883 Cr | 22.68 | |
| Mar2023 | ₹9,686 Cr | 6.34 | |
| Mar2022 | ₹9,108 Cr | - | |
Compare Total Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹93,957.5 Cr | -5.2% | 1.2% | -4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -5.2% |
1.2% |
-4.2% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses